medigraphic.com
SPANISH

Cirugía de Columna

ISSN 2992-7749 (Electronic)
ISSN 2992-7897 (Print)
Órgano Oficial de difusión científica de la Asociación Mexicana de Cirujanos de Columna A. C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • Políticas
    • Políticas éticas
    • Políticas de acceso abierto
    • Políticas de revisión de manuscritos
    • Políticas editoriales generales
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2024, Number 1

<< Back Next >>

Cir Columna 2024; 2 (1)

Evaluation of fluoroscopy-guided percutaneous biopsy as an auxiliary in the diagnosis of post COVID-19 pandemic vertebral destruction syndrome in a medical center of third level of reference

Contreras ZMF, González MA, Guzmán CJE, Sotelo MIJ
Full text How to cite this article 10.35366/114908

DOI

DOI: 10.35366/114908
URL: https://dx.doi.org/10.35366/114908

Language: Spanish
References: 25
Page: 19-25
PDF size: 223.76 Kb.


Key words:

biopsy, tumor, vertebral destruction syndrome, COVID-19.

ABSTRACT

Introduction: many conditions of the musculoskeletal system manifest as focal abnormalities, the vertebral body being a common site of injury. Vertebral destruction syndrome is defined as the set of pathologies that affect the structural integrity and modify the normal architecture of the vertebra, producing spinal instability and neurological deficit. It is a pathology with multiple etiology characterized by alterations of the structure and ultrastructure in the bone of the vertebral column; It is accompanied by pain and functional disability due to mechanical and neurological alterations. Its causes can be infectious: bacteria, mycobacteria, fungi and parasites; primary tumors: benign and malignant; tumor metastasis and metabolic diseases: osteoporosis, osteomalacia, Paget's disease, among others. The diagnosis of this syndrome is related to clinical data, laboratory studies and cabinet. Magnetic resonance imaging, computed tomography, fluoroscopy, and scintigraphy provide means for this. Another vital element is the biopsy of the vertebral body; since the precise diagnosis is essential to define the opportune and adequate treatment. The spine is the third most common site for the presentation of osteomyelitis. The etiology is due to any condition that causes bacteremia; the most common source is urinary tract infections. Bacteriologically, at the beginning of the 20th century, staphylococcus aureus was almost exclusively reported as a pathogen; currently, other types of microorganisms have been isolated, such as Gram negatives, Escherichia coli, Pseudomonas and Proteus. Neoplasms can originate from local lesions that develop within or adjacent to the vertebral column or from distant neoplasms. The incidence of primary spinal neoplasms is 2.5 to 8.5 per 100,000 people per year. Metastatic tumors are by far the most common; between 5 and 30% of all cancer patients have had spinal metastases, predominantly those derived from breast, lung, prostate, or lymphoreticular disease. Bone lesions can only be seen until there is 30 to 50% trabecular destruction. The definitive diagnosis of these pathologies is only possible by biopsy. Open biopsy maximizes and ensures tissue obtaining; however, imaging-guided percutaneous transpedicular biopsy has been shown to be very safe and can be performed at all levels of the spine. Thus, biopsies are divided into two types: open and closed, percutaneous or puncture. A large number of biopsies are still open, since they are continues to consider the election procedure. Depending on the instrumentation used and the type of sample obtained, percutaneous biopsy is divided into fine needle aspiration (FNAB) and tissue cylinder. Objective: to assess the usefulness of percutaneous transpedicular biopsy guided by Fluroscopy in conjunction with the systematization of studies as diagnostic tests of the etiology of vertebral destruction post-COVID-19 pandemic. Material and methods: prospective cross-sectional case series study with non-probabilistic sampling type of consecutive cases of a universe of subjects with a diagnosis of vertebral destruction syndrome in the period from November 1, 2021 to July 15, 2022 whose sample was 20 patients. The people studied were of both genders, over 18 years of age, with a complete vertebral destruction protocol and who had signed the informed consent; those previously diagnosed and those who had some pathology that prevented them from being in a prone position for taking the biopsy were not included, and those who refused to perform the procedure were excluded. Results: the male sex predominated with 55%. The lumbar spine was the most affected in 80%; 10% of the biopsies were reported as normal tissue, 20% with degenerative changes, 15% with inflammatory changes, 15% with primary tumor lesion, 5% with chronic osteomyelitis, 10% with tuberculosis, 15% with tumor metastasis, and in 10% necrotic devitalized bone tissue; in 2 cases, clinical correlation was performed between biopsy and systematization of studies to obtain the diagnosis. Conclusions: percutaneous transpedicular biopsy guided by fluoroscopy is a simple, useful, reliable, low-cost, and effective technique; in the study of destructive lesions of the spinal column.


REFERENCES

  1. Manual de Procedimientos del Servicio de Cirugía de Columna Vertebral. Instituto Nacional de Rehabilitación "Dr. Luis Miguel Rosales Olivares". México: 2006.

  2. Ozsarlak O, De Schepper AM, Wang X, De Raeve H. CT-guided percutaneous needle biopsy in spine lesions. JBR-BTR. 2003; 86: 294-296.

  3. Ashizawa R, Ohtsuka K, Kamimura M, Ebara S, Takaoka K. Percutaneous transpedicular biopsy of thoracic and lumbar vertebrae--method and diagnostic validity. Surg Neurol. 1999; 52: 545-551.

  4. Yaffe D, Greenberg G, Leitner J, Gipstein R, Shapiro M, Bachar GN. CT-guided percutaneous biopsy of thoracic and lumbar spine: A new coaxial technique. AJNR Am J Neuroradiol. 2003; 24: 2111-2113.

  5. Fernández-Portal L, Ortiz-Cruz YL, Ramos Pascua L. Tumores óseos primitivos y lesiones pseudotumorales de la columna vertebral. Rev Ortoped Traumatol. 1996; 40: 614-625.

  6. Duncan GA, Ferguson AB. Benign giant-cell tumor of the fourth lumbar vertebra. A case report. J Bone Joint Surg. 1936; 18: 769-772.

  7. Capener N. The evolution of lateral rachiotomy. J Bone Joint Surg Br. 1954; 36: 173-179.

  8. Michele AA, Krueger FJ. Surgical approach to the vertebral body. J Bone Joint Surg Am. 1949; 31: 873-878.

  9. Travaglini F. Tumours of the vertebral body: transpedicular biopsy with posterior surgical stabilisation. Bull Hosp Joint Dis. 1979; 40: 1-12.

  10. Roy-Camille R, Saillant G, Mamoudy P. Biopsy of the vertebral body using a posterior transpedicular approach. Rev Chir Orthop Reparatrice Appar Mot. 1983; 69: 147-149.

  11. Schmidek HH, Gomes FB, Seligson D, McSherry JW. Management of acute unstable thoracolumbar (T-11-L-1) fractures with and without neurological deficit. Neurosurgery. 1980; 7: 30-35.

  12. Fidler MW, Niers BB. Open transpedicular biopsy of the vertebral body. J Bone Joint Surg Br. 1990; 72: 884-885.

  13. Renfrew DL, Whitten CG, Wiese JA, El-Khoury GY, Harris KG. CT-guided percutaneous transpedicular biopsy of the spine. Radiology. 1991; 180: 574-576.

  14. Rosales-Olivares LM, Valle-Cerna I, Alpízar-Aguirre A, Miramontes-Martínez V, Arenas-Sordo MD, Reyes-Sánchez A. Evaluación de la biopsia percutánea en el diagnóstico del síndrome de destrucción vertebral torácico y lumbar. Cir Ciruj. 2007; 75: 459-463.

  15. Vieillard MH, Boutry N, Chastanet P, Duquesnoy B, Cotten A, Cortet B. Contribution of percutaneous biopsy to the definite diagnosis in patients with suspected bone tumor. Joint Bone Spine. 2005; 72: 53-60.

  16. Christodoulou A, Zidrou C, Savvidou OD, Givissis P, Apostolou T, Mavrogenis AF, et al. Percutaneous Harlow Wood needle biopsy of the spine: a retrospective analysis of 238 spine lesions. Orthopedics. 2005; 28: 784-789.

  17. Vieillard MH, Boutry N, Chastanet P, Duquesnoy B, Cotten A, Cortet B. Contribution of percutaneous biopsy to the definite diagnosis in patients with suspected bone tumor. Joint Bone Spine. 2005; 72: 53-60.

  18. Jelinek JS, Kransdorf MJ, Gray R, Aboulafia AJ, Malawer MM. Percutaneous transpedicular biopsy of vertebral body lesions. Spine (Phila Pa 1976). 1996; 21: 2035-2040.

  19. Kornblum MB, Wesolowski DP, Fischgrund JS, Herkowitz HN. Computed tomography-guided biopsy of the spine. A review of 103 patients. Spine (Phila Pa 1976). 1998; 23: 81-5.

  20. Sucu HK, Cicek C, Rezanko T, Bezircioglu H, Ersahin Y, Tunakan M, et al. Percutaneous computed-tomography-guided biopsy of the spine: 229 procedures. Joint Bone Spine. 2006; 73: 532-537.

  21. Weinstein JN. Surgical approach to spine tumors. Orthopaedics. 1989; 12: 897-905.

  22. Lis E, Bilsky MH, Pisinski L, Boland P, Healey JH, O'Malley B, et al. Percutaneous CT-guided biopsy of osseous lesion of the spine in patients with known or suspected malignancy. AJNR Am J Neuroradiol. 2004; 25: 1583-1588.

  23. Langer-Cherbit A, Chemla N, Vacherot B, Dupont AM, Godefroy D, Chevrot A. Intérêt et résultats de la biopsie osseuse profonde rachidienne radioguidée [Value and results of radioguided deep spinal biopsy]. J Radiol. 1994; 75: 603-608.

  24. Fernández-Portal L, Ortiz-Cruz YL. Ramos P. Tumores óseos primitivos y lesiones pseudotumorales de la columna vertebral. Rev Ortoped Traumatol. 1996; 40: 614-625.

  25. Gilbert RW, Kin JH, Posner JB. Epidural spinal cord compression from metastatic tumor: diagnosis and treatment. Ann Neurol. 1978; 3: 40-51.




Figure 1
Figure 2
Figure 3
Table 1

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Cir Columna. 2024;2